ALTERNATIVE INVESTMENTS, BIOTECH
Leonard Mazur
Chairman of the Board,
Citius Pharma
- Chairman of the Board, Citius Pharma
Follow
About Leonard
Leonard Mazur, chairman of Citius Pharmaceuticals, Inc., is a highly accomplished pharmaceutical executive with notable accomplishments in founding, building, and creating value and returns for investors. Mr. Mazur is a founder/co-founder of the following companies: Genesis, Triax, Akrimax, and Rouses Point. He previously served as executive vice president at Medicis Pharmaceutical Corporation and VP of sales & marketing at ICN Pharmaceuticals, Inc. and held management positions at BASF/Knoll Pharma and Cooper Labs.
Leonard's Videos
Citius Pharmaceuticals will present its progress in the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. Citius is advancing three product candidates: 1) Its late-stage lead asset Mino-Lok® is in Phase III trials and is enrolling patients, 2) Halo-Lido (CITI-002) is being prepared for a Phase IIb trial, and 3) Mino-Wrap™ (CITI-101) is in pre-clinical stage. The markets for these products are large, underserved, and provide unique opportunities for the company.
Leonard Mazur
BIOTECH
34:15
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of drug products that address important unmet medical needs. This presentation will provide details and statuses of the company's current products.
Leonard Mazur
ALTERNATIVE INVESTMENTS
29:44
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a specialty pharmaceutical company dedicated to the development and commercialization of drug products that address important unmet medical needs. This presentation will provide details and statuses of the company's current products.
Leonard Mazur
ALTERNATIVE INVESTMENTS
31:58